Early research (Phase 1)Study completedNCT01789086
What this trial is testing
A Randomised, Double-blind, Placebo-controlled Trial to Assess Safety, Tolerability and Pharmacokinetics of Liraglutide in Obese Adolescent Subjects Aged 12 to 17 Years
Who this might be right for
Metabolism and Nutrition DisorderObesity
Novo Nordisk A/S 21